Two new deals are announced in what is turning out to be an eventful week for SPACs. In today's dish, an oncology-focused drug developer who previously broke off a SPAC…
© 2024 Bill SPACman 📈
Substack is the home for great writing
Two new deals are announced in what is turning out to be an eventful week for SPACs. In today's dish, an oncology-focused drug developer who previously broke off a SPAC…